Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus
- PMID: 2840624
Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus
Abstract
Transgenic mice harboring a c-myc gene subjugated to the immunoglobulin heavy chain enhancer offer a unique opportunity to investigate whether deregulated myc expression potentiates the transformation of B lymphoid cells by other oncogenes. By assessing colony formation in semi-solid medium, we have compared the potential of bone marrow cells from E mu-myc mice and their normal littermates for transformation by Harvey murine sarcoma virus and Abelson murine leukemia virus. E mu-myc bone marrow yielded more lymphoid colonies than normal marrow after infection with Harvey virus. The increased transformation frequency may reflect increased clonogenicity due to complementation between myc and ras and/or the increased number of pre-B cells in E mu-myc marrow. Surprisingly, however, the number of lymphoid colonies induced by Abelson virus was not enhanced. Our interpretation of these results is that the primary Abelson target is more primitive than the pre-B cells expressing the E mu-myc transgene and is therefore not present at increased frequency in the E mu-myc marrow. The cells from most virus-infected E mu-myc colonies failed to grow indefinitely when placed in liquid culture in the absence of a feeder layer. Thus expression of a deregulated c-myc gene together with either v-Ha-ras or v-abl does not ensure fully autonomous growth of early B lymphoid cells.
Similar articles
-
Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.Oncogene. 1988 Jun;2(6):585-92. Oncogene. 1988. PMID: 2838788
-
The transgenic window on lymphoid malignancy.Princess Takamatsu Symp. 1989;20:297-309. Princess Takamatsu Symp. 1989. PMID: 2518688
-
A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice.Nature. 1988 Dec 1;336(6198):446-50. doi: 10.1038/336446a0. Nature. 1988. PMID: 3143076
-
Modulation of the haemopoietic system by murine retroviruses.Clin Haematol. 1984 Jun;13(2):447-59. Clin Haematol. 1984. PMID: 6088145 Review. No abstract available.
-
Arrested development: understanding v-abl.Bioessays. 1994 Jul;16(7):453-5. doi: 10.1002/bies.950160702. Bioessays. 1994. PMID: 7945272 Review.
Cited by
-
An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.EMBO J. 1990 Mar;9(3):897-905. doi: 10.1002/j.1460-2075.1990.tb08187.x. EMBO J. 1990. PMID: 2155783 Free PMC article.
-
NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression.Mol Cell Biol. 2002 Aug;22(15):5563-74. doi: 10.1128/MCB.22.15.5563-5574.2002. Mol Cell Biol. 2002. PMID: 12101248 Free PMC article.
-
Oncogene cooperation in lymphocyte transformation: malignant conversion of E mu-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl.Mol Cell Biol. 1989 Jan;9(1):67-73. doi: 10.1128/mcb.9.1.67-73.1989. Mol Cell Biol. 1989. PMID: 2784537 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials
Miscellaneous